BR112022015404A2 - Composições poliméricas mucoadesivas de dispensação de fármaco e métodos - Google Patents
Composições poliméricas mucoadesivas de dispensação de fármaco e métodosInfo
- Publication number
- BR112022015404A2 BR112022015404A2 BR112022015404A BR112022015404A BR112022015404A2 BR 112022015404 A2 BR112022015404 A2 BR 112022015404A2 BR 112022015404 A BR112022015404 A BR 112022015404A BR 112022015404 A BR112022015404 A BR 112022015404A BR 112022015404 A2 BR112022015404 A2 BR 112022015404A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- mucoadhesive
- composition
- molecular weight
- low molecular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062971882P | 2020-02-07 | 2020-02-07 | |
| PCT/CA2021/050136 WO2021155477A1 (en) | 2020-02-07 | 2021-02-06 | Mucoadhersive polymeric drug delivery compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022015404A2 true BR112022015404A2 (pt) | 2022-10-18 |
Family
ID=77199631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022015404A BR112022015404A2 (pt) | 2020-02-07 | 2021-02-06 | Composições poliméricas mucoadesivas de dispensação de fármaco e métodos |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12171833B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4100471A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7829490B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115916898B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021217503A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022015404A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3167259A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021155477A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116509794B (zh) * | 2023-05-19 | 2024-03-15 | 上海市肿瘤研究所 | 一种口服温敏凝胶制剂及其制备方法与应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0315194A (pt) | 2002-10-31 | 2005-08-23 | Umd Inc | Composições terapêuticas para liberação de droga para a, e através da, cobertura epitelial |
| US8486374B2 (en) * | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| WO2007083984A1 (en) * | 2006-01-23 | 2007-07-26 | Gwangju Institute Of Science And Technology | Conjugate comprising pharmaceutical active compound covalently bound to mucoadhesive polymer and transmucosal delivery method of pharmaceutical active compound using the same |
| KR100766820B1 (ko) * | 2006-01-23 | 2007-10-17 | 광주과학기술원 | 단백질 또는 펩타이드의 경점막 운반 시스템 |
| US10471150B2 (en) | 2010-01-20 | 2019-11-12 | Urogen Pharma Ltd. | Material and method for treating internal cavities |
| AU2013329077A1 (en) * | 2012-10-11 | 2015-04-23 | Tufts University | Compositions and methods for sustained delivery of glucagon-like peptide (GLP-1) receptor agonist therapeutics |
| JP2016510001A (ja) * | 2013-02-21 | 2016-04-04 | マサチューセッツ インスティテュート オブ テクノロジー | シスプラチン充填キトサンナノ粒子を含む標的化された頬側送達 |
| NZ728487A (en) | 2014-08-08 | 2021-07-30 | Shenzhen Hightide Biopharmaceutical Ltd | Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof |
| ES2883235T3 (es) * | 2015-09-09 | 2021-12-07 | Eth Zuerich | Hidrogeles macroporosos inyectables |
| US10369230B2 (en) * | 2017-04-06 | 2019-08-06 | National Guard Health Affairs | Sustained release of a therapeutic agent from PLA-PEG-PLA nanoparticles for cancer therapy |
| AU2018285975B2 (en) * | 2017-06-13 | 2023-11-16 | The University Of British Columbia | Polymeric paste compositions for drug delivery |
| US20210338887A1 (en) | 2018-07-12 | 2021-11-04 | The Trustees Of The University Of Pennsylvania | Systems for targeted tissue biosealing or repair |
-
2021
- 2021-02-06 CA CA3167259A patent/CA3167259A1/en active Pending
- 2021-02-06 CN CN202180026836.7A patent/CN115916898B/zh active Active
- 2021-02-06 EP EP21751363.9A patent/EP4100471A4/en active Pending
- 2021-02-06 WO PCT/CA2021/050136 patent/WO2021155477A1/en not_active Ceased
- 2021-02-06 JP JP2022547849A patent/JP7829490B2/ja active Active
- 2021-02-06 BR BR112022015404A patent/BR112022015404A2/pt active Search and Examination
- 2021-02-06 AU AU2021217503A patent/AU2021217503A1/en active Pending
- 2021-02-06 US US17/797,627 patent/US12171833B2/en active Active
-
2024
- 2024-11-12 US US18/945,029 patent/US20250205340A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250205340A1 (en) | 2025-06-26 |
| JP2023513175A (ja) | 2023-03-30 |
| AU2021217503A1 (en) | 2022-09-15 |
| EP4100471A1 (en) | 2022-12-14 |
| CN115916898B (zh) | 2026-04-28 |
| JP7829490B2 (ja) | 2026-03-13 |
| US12171833B2 (en) | 2024-12-24 |
| CN115916898A (zh) | 2023-04-04 |
| EP4100471A4 (en) | 2024-03-13 |
| CA3167259A1 (en) | 2021-08-12 |
| US20230042600A1 (en) | 2023-02-09 |
| WO2021155477A1 (en) | 2021-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022013746A2 (pt) | Formulação aquosa de cagrilintida, formulação aquosa de semaglutida, dispositivo médico, e, combinação de dose fixa | |
| BRPI0511966A (pt) | composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons | |
| MX347056B (es) | Composiciones farmaceuticas. | |
| BR112015017246A8 (pt) | composição farmacêutica aquosa, seu uso e seringa | |
| NO20084608L (no) | Pegylert faktor VIII | |
| BRPI0510477A8 (pt) | composições e sistemas para a formação de biomateriais reticulados e métodos associados de preparação e uso | |
| BR112014027834A2 (pt) | composições de nanopartícula lipídica para entrega de oligonucleotídeos antissenso | |
| CY1118017T1 (el) | Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
| BR112012002709A2 (pt) | formulações de liberação controlada de muteínas de lipocalina | |
| BRPI0615860B8 (pt) | composição farmacêutica de liberação prolongada monolítica sólida | |
| BR9815239A (pt) | Copolìmeros tribloco de polientileno glicol depoli(lactìdio-co-glicolìdio) de baixo peso molecularbiodegradáveis tendo propriedades deresfriamento térmico reverso | |
| BR112022010574A2 (pt) | Composições farmacêuticas compreendendo cabotegravir | |
| CY1119829T1 (el) | Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου | |
| BR112015032225A2 (pt) | composição, oligômero, polímero ou lipoide, uso de uma composição, e, método para dispensação de rna a uma célula alvo ou tecido | |
| WO2011079279A3 (en) | Nanoconjugates and nanoconjugate formulations | |
| ECSP12011953A (es) | Formulaciones de espuma de polímero estabilizado libre de emulsionante | |
| BR112022015404A2 (pt) | Composições poliméricas mucoadesivas de dispensação de fármaco e métodos | |
| BR112022002720A2 (pt) | Formulações de conjugados de benzazepinas e usos das mesmas | |
| BR112017026287A2 (pt) | composições de hidroxipropil beta-ciclodextrina e métodos | |
| BR112017007669A2 (pt) | composição farmacêutica com estabilidade melhorada | |
| HRP20220537T1 (hr) | Sastavi za ubrizgavanje koji sadrže letrozol ili anastrozol | |
| ECSP17081071A (es) | Composiciones de matriz polimérica tópicas que comprenden una alta concentración de hialuronato de sodio bio-fermentado y sus usos | |
| Da Silva et al. | Boosting the photodynamic activity of erythrosine B by using thermoresponsive and adhesive systems containing cellulose derivatives for topical delivery | |
| BR112022001109A2 (pt) | Matriz de tecido-adesivo e seus usos. | |
| EP4384156A4 (en) | HIGH CONCENTRATION MOLECULAR IODINE COMPOSITIONS, PHARMACEUTICAL FORMULATIONS, PREPARATION AND USES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] |